Does Rallies show Form 4 insider transactions for OPCH?

Yes. Rallies tracks OPCH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is OPCH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OPCH. It does not provide personalized investment advice.

OPCH (Option Care Health, Inc. Common Stock) Stock Analysis - Insider Trades

Option Care Health, Inc. Common Stock (OPCH) is a publicly traded Healthcare sector company. As of May 20, 2026, OPCH trades at $21.97 with a market cap of $3.09B and a P/E ratio of 17.74. OPCH moved +6.54% today. Year to date, OPCH is -30.92%; over the trailing twelve months it is -32.78%. Its 52-week range spans $18.01 to $36.80. Analyst consensus is strong buy with an average price target of $30.73. Rallies surfaces OPCH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading OPCH stock inside the company?

Recent OPCH insider activity includes SULLIVAN TIMOTHY P bought 24.15K, KRAEMER HARRY M JANSEN JR bought 36.61K, Sethna Meenal bought 16.23K, RADEMACHER JOHN CHARLES bought 12.50K, and Pate R Carter sold 30.29K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

OPCH Key Metrics

Key financial metrics for OPCH
Metric	Value
Price	$21.97
Market Cap	$3.09B
P/E Ratio	17.74
EPS	$1.23
Dividend Yield	0.00%
52-Week High	$36.80
52-Week Low	$18.01
Volume	4.38M
Avg Volume	0
Revenue (TTM)	$5.00B
Net Income	$211.82M
Gross Margin	20.27%

Recent OPCH Insider Trades

SULLIVAN TIMOTHY P bought 24.15K (~$499.67K) on May 7, 2026.
KRAEMER HARRY M JANSEN JR bought 36.61K (~$783.77K) on May 4, 2026.
Sethna Meenal bought 16.23K (~$327.07K) on May 4, 2026.
RADEMACHER JOHN CHARLES bought 12.50K (~$264.71K) on May 4, 2026.
Pate R Carter sold 30.29K (~$970.62K) on Feb 27, 2026.

Latest OPCH News

Option Care Health Reports 8.8% Q4 Sales Growth, Slightly Lower Annual Guidance — Feb 24, 2026
Option Care Health Raises FY25 EPS Outlook to $1.72–1.76 and Hits 52-Week High — Jan 15, 2026
Morgan Stanley Lift to $38 Target Drives Option Care Health to 52-Week High — Jan 15, 2026
Option Care Health Reports $1.47B Q4 Revenue, Doubles Buyback Authorization — Jan 15, 2026
Option Care Health Hits $35.54 High After Morgan Stanley Lifts Price Target to $38 — Jan 15, 2026

OPCH Analyst Consensus

12 analysts cover OPCH: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.73.

Common questions about OPCH

Who is trading OPCH stock inside the company?: Recent OPCH insider activity includes SULLIVAN TIMOTHY P bought 24.15K, KRAEMER HARRY M JANSEN JR bought 36.61K, Sethna Meenal bought 16.23K, RADEMACHER JOHN CHARLES bought 12.50K, and Pate R Carter sold 30.29K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for OPCH?: Yes. Rallies tracks OPCH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is OPCH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OPCH. It does not provide personalized investment advice.